![](/img/cover-not-exists.png)
Phase I safety, pharmacokinetic, and pharmacodynamic study of the oral phosphatidylinositol-3-kinase and mTOR inhibitor BGT226 in patients with advanced solid tumors
Markman, B., Tabernero, J., Krop, I., Shapiro, G. I., Siu, L., Chen, L. C., Mita, M., Melendez Cuero, M., Stutvoet, S., Birle, D., Anak, O., Hackl, W., Baselga, J.Volume:
23
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mds011
Date:
September, 2012
File:
PDF, 362 KB
english, 2012